ArticleiLIVER2024

Tumor burden score and alpha-fetoprotein level predict prognosis of patients with unresectable hepatocellular carcinoma treated with tyrosine kinase inhibitor and anti-PD-1 antibody.

Shichuan Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.